Categories
Business

Cochlear Implant Market Share To Witness Steady Rise In Coming Decade : Fact.MR

The global sales of Cochlear Implant Market in 2021 was held at US$ 2.2Bn. With 14.1%, theprojectedmarketgrowthduring2022 – 2032 is expected to be significantly higher than the historical growth. Unilateral Implants are expected to be the highest revenue generating segment, projected to grow at a CAGR of over 14.3% during 2022 – 2032.

For critical insights on this market, request for More Info – https://www.factmr.com/connectus/sample?flag=S&rep_id=7244

Market Segments Covered in Cochlear Implant Market Analysis

  • By Fitting Type

    • Unilateral Implants
    • Bilateral Implants
  • By End-Use

    • Adult
    • Pediatric
  • By Region

    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

Request more information about Report Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=7244

Competitive Analysis

Players in the market are constantly developing innovative solutions as well as extending their product offerings. To help healthcare organisations combat the Covid-19 pandemic, and preserve competitive advantage in the market, the companies are focused on their alliances, technology collaborations, and product launch strategies.

Some of the recent developments of key Cochlear Implant providers are as follows:

  • In April 2022Cochlear Ltd.‘s Cochlear Nucleus Implants were approved by the FDA for the treatment of unilateral hearing loss (ULH) or single-sided deafness (SDD).
  • In January 2022, TODOC, a South Korean company that specializes in neural prosthetic devices and neuromodulation systems, has announced that its artificial cochlear device ‘SULLIVAN’ will be unveiled at the “CES 2022” in Las Vegas.
  • In June 2021, Oticon Medical received premarket approval (PMA) from the United States Food and Drug Administration (U.S. FDA) for its Neuro System (cochlear implant system) to treat patients aged 18 years or more with bilateral severe-to-profound sensorineural hearing loss who receive limited benefit from appropriately fitted hearing aids.
  • In December 2020, after receiving FDA approval to expand its product offerings, Sonova launched two new sound processors, Sky CI Marvel and Nada CI Marvel.

Similarly, recent developments related to companies Cochlear Implant services have been tracked by the team at Fact.MR, which are available in the full report.

For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7244

What is the impact of Covid-19 on Cochlear Implant Market?

COVID-19 established limitations on audiology surgery and therapy services when it first appeared. The possibility of aerosolizing the virus while drilling in the mastoid cavity increased the danger of infection during neurotological (a subset of ENT) procedures. As a result, individuals were screened for COVID-19 prior to surgery, which caused procedures to be postponed. In addition, appointments for the rehabilitation phase following a cochlear implant operation were cancelled or postponed.

Surgical procedures are fewer today than in the early months of the conflict as a result of eased restrictions against coronaviruses in several countries. Although this contributed to the emergent risk of cochlear implant surgery and other procedures, it also led to thrive in brand-new study. At Nottingham University Hospitals in July 2020, ENT doctors and researchers created a new personal protective equipment solution for cochlear implantation surgeries, which enabled the procedure to be completed more quickly.

For More Insight- https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com